Cassava Sciences Inc Equity-NMS: SAVA

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$34.14

52W high :

$62.49

1Y :

-34.23%

5Y :

710.89%

Shares O/S :

40.07 M

Market cap :

1.4 B

What is the share price of Cassava Sciences Inc today?

Cassava Sciences Inc (SAVA) share price as of October 11, 2022, is $35.77. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Cassava Sciences Inc?

Yes, Indian Investors can invest in the Cassava Sciences Inc (SAVA) Share by opening an international trading account with Angel One.

How can I purchase Cassava Sciences Inc shares in India?

Purchasing Cassava Sciences Inc (SAVA) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Cassava Sciences Inc (SAVA) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Cassava Sciences Inc?

Yes, you can purchase fractional shares of Cassava Sciences Inc (SAVA) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Cassava Sciences Inc?

The market capitalization of Cassava Sciences Inc on December 2, 2022, is $1.43 B.

In which sector Cassava Sciences Inc belongs?

Cassava Sciences Inc operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Cassava Sciences Inc stocks?

In order to invest in Cassava Sciences Inc (SAVA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Cassava Sciences, Inc. is a clinical-stage biotechnology company. The Company is primarily focused on developing the drug for the treatment of neurodegenerative diseases, such as Alzheimer's disease. The Company develops pharmaceutical product candidates that offer improvements to patients and healthcare professionals. The Company’s products include Simufilam and SavaDx. Its lead therapeutic product candidate, Simufilam, is a small molecule (oral) drug. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain. The Company is conducting a Phase III program with Simufilam in patients with mild-to-moderate Alzheimer’s disease dementia. Its investigational product candidate, SavaDx, is an early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood. SavaDx is designed as an antibody-based detection system for altered filamin A (FLNA).